Federal Cannabis Reform Is Coming

Here's What Operators Should Do Right Now
The businesses that prepare before regulations arrive may gain the biggest advantage when the industry transitions.
The cannabis industry has spent years debating federal reform, rescheduling, FDA involvement, interstate commerce, pharmaceutical entry, institutional capital. These questions matter. But there is a more important question operators should be asking today: What should we be doing right now?
Regardless of how quickly federal reform unfolds, one thing is increasingly clear: the businesses that prepare early will likely have a significant advantage over those that wait.
The good news is that operators do not need to guess what the future looks like. The standards already exist. The roadmap is already visible. Preparation can start today.
Stop waiting for regulatory certainty
One of the biggest mistakes operators make is assuming they need final federal rules before taking action. By the time federal expectations are finalized, lenders will already be adapting, insurers will already be evaluating readiness, investors will already be asking questions, and buyers will already be conducting deeper diligence.
Preparation does not require perfection. It requires progress.
Ten steps toward federal readiness
Step 1: Build a Quality Management System
Step 2: Organize your documentation
Step 3: Implement CAPA
Step 4: Prepare for GACP
Step 5: Evaluate GMP readiness
Step 6: Conduct internal audits
Step 7: Build traceability systems
Step 8: Strengthen risk management
Step 9: Think beyond compliance
Step 10: Create a readiness roadmap
A Quality Management System is the foundational investment every cannabis business should prioritize, the operating system that makes every future compliance requirement easier to meet. Without it, each new standard becomes harder to implement. With it, everything builds on a common foundation.
Documentation is no longer paperwork. It is infrastructure. Future-ready businesses establish controlled SOP libraries with version tracking, complete training records, equipment maintenance logs, and vendor qualification files.
A structured CAPA program separates mature operations from reactive ones. Cultivators should familiarize themselves with Good Agricultural and Collection Practices (GACP), covering water quality, sanitation, environmental monitoring, pesticide management, and harvest controls, as cannabis integrates further into medical and pharmaceutical supply chains.
Manufacturers should evaluate their readiness for GMP-style operations across sanitation systems, batch records, process controls, calibration programs, and supplier controls. Future opportunities in edibles, extracts, supplements, and pharmaceutical partnerships will increasingly depend on these capabilities.
Internal audits find problems before someone else does, and finding problems early is significantly less expensive than finding them later. Businesses that audit themselves regularly are typically better prepared for inspections, lender reviews, insurance underwriting, and acquisitions.
Think beyond compliance
Federal readiness is not simply about avoiding enforcement. The real opportunity is much larger. Businesses that prepare early may be better positioned across multiple dimensions:
Insurance savings, Lender access, M&A positioning, Pharmaceutical partnerships, International expansion, Enterprise value growth
Better controls improve underwriting confidence. Operational maturity supports stronger financing conversations. Buyers increasingly value businesses with documented systems. Quality systems create credibility for pharmaceutical partnerships, and programs such as GACP and GMP support export readiness.
Create a readiness roadmap
The strongest operators are already moving from reactive compliance toward strategic preparation. A readiness roadmap should sequence priorities across three horizons:
30–90 daysImmediate priorities: documentation gaps, QMS foundation, internal audit baseline
6–12 monthsIntermediate priorities: CAPA implementation, GACP/GMP assessment, traceability systems
1–3 yearsLong-term goals: certification pathways, pharmaceutical readiness, international market access
Federal readiness is a journey, not a single project. The operators who begin now will likely spend the transition years growing. Those who wait may spend them catching up.
The transition has already begun.
At Red Wolf Risk we help cannabis operators build the systems, documentation, quality infrastructure, and operational readiness programs necessary to navigate federal reform and capitalize on the opportunities ahead.
The best time to prepare was yesterday · The second-best time is today
Alex Hearding is the Founder and President of Red Wolf Risk and has more than 17 years of experience in cannabis operations, risk management, quality systems, and regulatory compliance.
This piece is part of Chronic Risk, the insights publication of Red Wolf Risk. Read the full article, comments, and related essays on the original publication.
Read the full article